Tunisia's Heartbeat : Pioneering Isotopic Techniques in Cardiac Viability Among Resource Challenges.

Myocardial viability scintigraphy (MVS) identified 62.5% of myocardial territories as non-viable and 37.5% as hibernating.

• Study included 40 patients for whom myocardial viability studies were indicated.
• Isotopic examinations and coronary angiographies were performed between January 2022 and June 2023.
• This was a prospective descriptive and analytical study design.

Results from MVS perfectly matched those obtained by 18FDG PET-CT.

• All patients underwent both isotopic examinations (MVS) and 18FDG PET-CT.
• The paper states results 'perfectly matched those obtained by 18FDG PET-CT.'
• This finding supports the diagnostic value of MVS as comparable to metabolic imaging.

MVS significantly influenced therapeutic decision-making, with revascularization indicated in 40% of patients with viable myocardium.

• Revascularization was indicated in 40% of patients with viable (hibernating) myocardium.
• Medical treatment was prescribed for all patients with non-viable myocardium.
• MVS is described as 'a highly reliable tool that significantly influenced therapeutic decisions.'

Patients with hibernating myocardium treated with revascularization showed significant improvement in left ventricular ejection fraction (LVEF) compared to those treated medically.

• The difference in LVEF improvement between revascularization and medical treatment groups was statistically significant (p=0.02).
• This comparison was made during a follow-up period.
• The finding applied specifically to the group with viable (hibernating) myocardium.

The non-viable myocardium group had a higher mortality rate and lower survival rate compared to the viable myocardium group.

• Mortality rate was 12% in the non-viable group compared to 6.7% in the viable group.
• Survival rates were 85% in the non-viable group versus 93% in the viable group.
• These results indicate that nuclear imaging techniques can provide information on long-term prognosis.

This study represents the first prospective study conducted in Tunisia assessing the contribution of isotopic examinations in evaluating myocardial viability.

• The study was conducted in a resource-limited healthcare setting in Tunisia.
• The study period ran from January 2022 to June 2023.
• The authors highlight the context of limited healthcare resources as a backdrop for the study's significance.